Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Debt (2018 - 2025)

Historic Total Debt for Rockwell Medical (RMTI) over the last 10 years, with Q3 2025 value amounting to $10.5 million.

  • Rockwell Medical's Total Debt fell 112.6% to $10.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 million, marking a year-over-year decrease of 112.6%. This contributed to the annual value of $10.8 million for FY2024, which is 46.33% up from last year.
  • As of Q3 2025, Rockwell Medical's Total Debt stood at $10.5 million, which was down 112.6% from $11.1 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Total Debt ranged from a high of $21.2 million in Q3 2021 and a low of $9.0 million during Q3 2023
  • Moreover, its 5-year median value for Total Debt was $10.8 million (2024), whereas its average is $13.4 million.
  • In the last 5 years, Rockwell Medical's Total Debt crashed by 5533.62% in 2022 and then surged by 1891.32% in 2024.
  • Rockwell Medical's Total Debt (Quarter) stood at $20.6 million in 2021, then crashed by 55.34% to $9.2 million in 2022, then increased by 17.49% to $10.8 million in 2023, then grew by 0.46% to $10.8 million in 2024, then fell by 2.82% to $10.5 million in 2025.
  • Its last three reported values are $10.5 million in Q3 2025, $11.1 million for Q2 2025, and $11.0 million during Q1 2025.